Shareholders Fight Bid To Dismiss Part Of Apotex Suit

Law360, New York (December 18, 2007, 12:00 AM EST) -- The plaintiffs in a securities lawsuit accusing Bristol-Myers Squibb Co. and two former officers of deceiving investors with its controversial patent deal with Apotex Corp. are fighting an effort to toss part of the suit.

In a motion filed Monday in the U.S. District Court for the Southern District of New York, counsel for the plaintiffs said they had adequately stated their case against former chief executive officer Peter Dolan.

The case alleges BMS, Dolan and another top former officers deceived investors by repeatedly saying that...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.